Segment Information (Tables)
|
12 Months Ended |
Sep. 24, 2023 |
|---|
| Segment Reporting [Abstract] |
|
| Revenues, EBT, and Assets for reportable segments |
The table below presents revenues and EBT for reportable segments (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
2022 |
|
2021 |
| Revenues: |
|
|
|
|
|
| QCT |
$ |
30,382 |
|
|
$ |
37,677 |
|
|
$ |
27,019 |
|
| QTL |
5,306 |
|
|
6,358 |
|
|
6,320 |
|
| QSI |
28 |
|
|
31 |
|
|
45 |
|
| Reconciling items |
104 |
|
|
134 |
|
|
182 |
|
| Total |
$ |
35,820 |
|
|
$ |
44,200 |
|
|
$ |
33,566 |
|
| EBT: |
|
|
|
|
|
| QCT |
$ |
7,924 |
|
|
$ |
12,837 |
|
|
$ |
7,763 |
|
| QTL |
3,628 |
|
|
4,628 |
|
|
4,627 |
|
| QSI |
(12) |
|
|
(279) |
|
|
916 |
|
| Reconciling items |
(4,097) |
|
|
(2,188) |
|
|
(3,032) |
|
| Total |
$ |
7,443 |
|
|
$ |
14,998 |
|
|
$ |
10,274 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reconciling items for reportable segments - revenues |
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
2022 |
|
2021 |
| Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
| Nonreportable segments |
|
|
|
|
|
|
|
$ |
144 |
|
|
$ |
134 |
|
|
$ |
128 |
|
Unallocated revenues |
|
|
|
|
|
|
|
(40) |
|
|
— |
|
|
54 |
|
|
|
|
|
|
|
|
|
$ |
104 |
|
|
$ |
134 |
|
|
$ |
182 |
|
| EBT: |
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated revenues |
|
|
|
|
|
|
|
$ |
(40) |
|
|
$ |
— |
|
|
$ |
54 |
|
| Unallocated cost of revenues |
|
|
|
|
|
|
|
(205) |
|
|
(266) |
|
|
(277) |
|
| Unallocated research and development expenses |
|
|
|
|
|
|
|
(2,034) |
|
|
(1,767) |
|
|
(1,820) |
|
| Unallocated selling, general and administrative expenses |
|
|
|
|
|
|
|
(588) |
|
|
(609) |
|
|
(538) |
|
Unallocated other (expense) income (Note 2) |
|
|
|
|
|
|
|
(862) |
|
|
1,059 |
|
|
— |
|
| Unallocated interest expense |
|
|
|
|
|
|
|
(694) |
|
|
(490) |
|
|
(559) |
|
Unallocated investment and other income (expense), net |
|
|
|
|
|
|
|
364 |
|
|
(91) |
|
|
166 |
|
| Nonreportable segments |
|
|
|
|
|
|
|
(38) |
|
|
(24) |
|
|
(58) |
|
|
|
|
|
|
|
|
|
$ |
(4,097) |
|
|
$ |
(2,188) |
|
|
$ |
(3,032) |
|
|
| Reconciling items for reportable segments - EBT |
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
2022 |
|
2021 |
| Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
| Nonreportable segments |
|
|
|
|
|
|
|
$ |
144 |
|
|
$ |
134 |
|
|
$ |
128 |
|
Unallocated revenues |
|
|
|
|
|
|
|
(40) |
|
|
— |
|
|
54 |
|
|
|
|
|
|
|
|
|
$ |
104 |
|
|
$ |
134 |
|
|
$ |
182 |
|
| EBT: |
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated revenues |
|
|
|
|
|
|
|
$ |
(40) |
|
|
$ |
— |
|
|
$ |
54 |
|
| Unallocated cost of revenues |
|
|
|
|
|
|
|
(205) |
|
|
(266) |
|
|
(277) |
|
| Unallocated research and development expenses |
|
|
|
|
|
|
|
(2,034) |
|
|
(1,767) |
|
|
(1,820) |
|
| Unallocated selling, general and administrative expenses |
|
|
|
|
|
|
|
(588) |
|
|
(609) |
|
|
(538) |
|
Unallocated other (expense) income (Note 2) |
|
|
|
|
|
|
|
(862) |
|
|
1,059 |
|
|
— |
|
| Unallocated interest expense |
|
|
|
|
|
|
|
(694) |
|
|
(490) |
|
|
(559) |
|
Unallocated investment and other income (expense), net |
|
|
|
|
|
|
|
364 |
|
|
(91) |
|
|
166 |
|
| Nonreportable segments |
|
|
|
|
|
|
|
(38) |
|
|
(24) |
|
|
(58) |
|
|
|
|
|
|
|
|
|
$ |
(4,097) |
|
|
$ |
(2,188) |
|
|
$ |
(3,032) |
|
|
| Revenue from external customers attributed to foreign countries by geographic area |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
2022 |
|
2021 |
| China (including Hong Kong) |
$ |
22,382 |
|
|
$ |
28,119 |
|
|
$ |
22,512 |
|
| Vietnam |
4,551 |
|
|
6,063 |
|
|
3,114 |
|
| South Korea |
3,272 |
|
|
3,164 |
|
|
2,368 |
|
| United States |
1,259 |
|
|
1,482 |
|
|
1,406 |
|
| Other foreign |
4,356 |
|
|
5,372 |
|
|
4,166 |
|
|
$ |
35,820 |
|
|
$ |
44,200 |
|
|
$ |
33,566 |
|
|